Novartis Investigative Site

Saarbrücken, Saarland 66113

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer, Leukaemia, Lymphocytic, Chronic, Neoplasms, Breast, Purpura, Thrombocytopaenic, Idiopathic

Studies at this site

• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia — Completed
• Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia — Stopped early
• EXTEND (Eltrombopag Extended Dosing Study) — Completed
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING